3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dicke, KA; Dimopoulos, MA; Huan, SD; Jagannath, S; LeMaistre, CF; Spinolo, JA; Spitzer, G; Yau, JC; Zagars, GK; Zander, AR | 1 |
| Dicke, KA; Horwitz, LJ; Jagannath, S; Kantarjian, HM; Keating, MJ; McCredie, KB; Spitzer, G; Vellekoop, L; Zander, AR | 1 |
1 trial(s) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Bone Marrow Transplantation; Child; Combined Modality Therapy; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Whole-Body Irradiation | 1994 |
1 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Combined Modality Therapy; Evaluation Studies as Topic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Preoperative Care; Transplantation, Homologous; Whole-Body Irradiation | 1989 |